The Canadian Association for Healthcare Reimbursement offers the Market Access 101 and 201 courses. Market Access 101 covers the fundamentals of reimbursement in Canada. The course will explore the market access decision-making pathway for pharmaceuticals from Health Canada approval through reimbursement in private and public drug plans.
The theme of Market Access 201 is "Canadian Perspective on Value: Is Our System Helping or Hindering Innovation?" The course offers views from industry experts, payers, decision-makers, patient organizations, and others, on topics of direct importance to market access professionals in the pharmaceutical industry.
IQVIA Principal for Price Regulations Consulting, Joan McCormick, will present sessions at Market Access 101 and 201 on the role and policies of the Patented Medicine Prices Review Board.